Thermo Fisher Scientific, a precision laboratory equipment company, recently announced the development of the Thermo Scientific Miniflex peristaltic pump, which improves the precision and reliability of bioprocessing systems and research processes.
“Peristaltic pumps play an important role in many applications within research and industrial settings. In bioprocessing environments, researchers are facing new requirements for speed, efficiency and reliability in liquid transfer,” said Gregg Johnson, senior marketing manager, fluid handling for Thermo Fisher Scientific in a press release. “The advancements of the new Miniflex address these laboratory challenges for a wide variety of fluid and media transfer needs.”
This is just one of many new product launches in the Single-Use Bioprocessing Systems Market that is driving market growth at a whopping CAGR of 38.44 percent for the 2013-2018 period.
Apart from Thermo Scientific, many other vendors have launched new products with new added features such as increased safety, comfort, and performance. For example, in early 2014, Finesse Solutions Inc., a manufacturer of measurement and control solutions for life sciences process applications, launched G3Lite SmartControllers for upstream cell culture and fermentation.
Another example is Medline Industries Inc. which launched single-use conductivity sensors to compliment the popular PendoTECH single-use pressure, temperature, UV absorbance sensors for bioprocess operations. Such launches are expected to accelerate the growth of the Global Single-Use Bioprocessing Systems market over the next few years.
This trend for developing new and improved bioprocessing technology is due in large part to the explosive demand for biopharmaceuticals. Across the world, there is a steadily growing aging population that is more prone to suffering from various diseases. The aging population in the United States alone is expected to double and reach a total of 71 million by 2030. Cardiovascular diseases, Alzheimer’s, and cancer are some of the most common diseases seen in the aged.
This steadily growing aging population increases the prevalence of these diseases, which in turn increases the demand for biopharmaceuticals. Most of these biopharmaceuticals are biologics, which require bio-processing systems for their large-scale production to meet the demands of the industry. This in turn necessitates the usage and adoption of bio-processing systems with better process efficiency and throughput.
The Global Single-Use Bioprocessing Systems market is broadly classified into two segments: R&D Support Single-use Systems and Good Manufacturing Practice (GMP) Single-use Systems.
The R&D support laboratories adopt single-use systems for optimizing the development of biologics and biopharmaceuticals. They are also used by research centers and academic institutions for reducing the long sterilization process and simplifying research. The GMP single-use systems are employed by biopharmaceutical companies and other bio-manufacturing companies for reorienting their business and manufacturing processes.
The R&D segment accounted for well over half of the share of the Single-Use Bioprocessing Market, which enables companies like Thermo Scientific, Finesse Solutions and Medline Industries to not only design and develop new products, but to explore new discoveries by collaborating with other vendors in the market.
Owing to the growing potential of the Global Single-use Bio-processing Systems market, many bio-processing systems manufacturers collaborate to develop new platforms for the cultivation of cells or to develop new systems. For example, Thermo Fisher’s new bioreactor controllers for use with single-use systems were developed with technology integration collaborator, Finesse. These bioreactor controllers offer biopharmaceutical companies the choice, performance, and flexibility required for a wide range of research and manufacturing applications.
Another example is Sartorius‘s collaboration with Refine Technology LLC for the development of a robust platform for high-density cell cultivation. This platform will enable fast and easy connection of the alternating tangential flow system to Sartorius Stedim Biotech’s field-proven single-use BIOSTAT bioreactors. Moreover, the partnership would enable the development of new designs of clinical analyzers and enable vendors to stay competitive in the market. This in turn could boost the growth of the Global Single-use Bio-processing Systems market.
